2013
DOI: 10.1186/2052-3211-6-10
|View full text |Cite
|
Sign up to set email alerts
|

Malaria treatment policies and drug efficacy in Haiti from 1955-2012

Abstract: ObjectivesChloroquine (CQ), after 67 years of use in Haiti, is still part of the official treatment policy for malaria. Several countries around the world have used CQ in the past due to its low incidence of adverse events, therapeutic efficacy, and affordability, but were forced to switch treatment policy due to the development of widespread CQ resistance. The purpose of this paper was to compile literature on malaria treatment policies and antimalarial drug efficacy in Haiti over 67-year period.MethodsA syst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 13 publications
(26 reference statements)
0
3
0
Order By: Relevance
“…Investigations of P. falciparum resistance to chloroquine in Haiti have been numerous and ongoing since 1981. Even the first reports in the early 1980s found in vivo and in vitro evidence for possible resistance to chloroquine (27,28), which had been in use in Haiti at least since the 1950s (29). With the advent of mutations in the Pfcrt gene serving as molecular markers for chloroquine resistance (18,19), the Pfcrt K76T haplotype has been reported sporadically in Haiti since 2009, but always at very low rates (2,30).…”
Section: Discussionmentioning
confidence: 99%
“…Investigations of P. falciparum resistance to chloroquine in Haiti have been numerous and ongoing since 1981. Even the first reports in the early 1980s found in vivo and in vitro evidence for possible resistance to chloroquine (27,28), which had been in use in Haiti at least since the 1950s (29). With the advent of mutations in the Pfcrt gene serving as molecular markers for chloroquine resistance (18,19), the Pfcrt K76T haplotype has been reported sporadically in Haiti since 2009, but always at very low rates (2,30).…”
Section: Discussionmentioning
confidence: 99%
“…1 Chloroquine (CQ) has been used to treat malaria in Haiti as either a monotherapy or combination drug since 1955. [2][3][4] Despite widespread resistance to CQ worldwide, in the Caribbean and Central America, P. falciparum remains sensitive to CQ. A 3-day course of CQ plus a single dose of primaquine (PQ) (to target the gametocytes and prevent ongoing transmission) is the first-line treatment for uncomplicated malaria in Haiti.…”
Section: Introductionmentioning
confidence: 99%
“…Haiti is a unique country in the Americas because malaria is caused there mainly by Plasmodium falciparum . Despite chloroquine being used for treatment of malaria since 1955, P. falciparum is generally still susceptible to this drug ( 1 ). Thus, chloroquine, plus a single dose of the gametocytocidal drug primaquine, is still the first-line treatment for uncomplicated malaria in Haiti, as indicated by the ministry of health.…”
mentioning
confidence: 99%